What do Cochrane systematic reviews say about diabetic retinopathy?

Detalhes bibliográficos
Autor(a) principal: Mozetic, Vania [UNIFESP]
Data de Publicação: 2017
Outros Autores: Daou, Julia Pozzetti [UNIFESP], Martimbianco, Ana Luiza Cabrera [UNIFESP], Riera, Rachel [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
dARK ID: ark:/48912/001300000c1zg
DOI: 10.1590/1516-3180.2016.0356040117
Texto Completo: http://dx.doi.org/10.1590/1516-3180.2016.0356040117
https://repositorio.unifesp.br/handle/11600/56341
Resumo: CONTEXT AND OBJECTIVE: Diabetic retinopathy is a disease caused by increased permeability of retinal vessels. Its incidence and prevalence have been increasing due to urbanization, greater life expectancy and the habits of modern life. Its onset is insidious and it may lead to blindness in 75% of individuals who have been diabetic for more than 20 years. The aim here was to evaluate the evidence from Cochrane systematic reviews on interventions relating to diabetic retinopathy. DESIGN AND SETTING: Review of systematic reviews, conducted at Cochrane Brazil. METHODS: We included Cochrane systematic reviews on interventions relating to diabetic retinopathy. Two researchers evaluated the inclusion criteria, summarized the reviews and presented the results narratively. RESULTS: Ten reviews met the inclusion criteria. They showed some evidence of benefits from: (a) photocoagulation for diabetic retinopathy
id UFSP_ce80f3c78e1aad6ec439ae179039f671
oai_identifier_str oai:repositorio.unifesp.br/:11600/56341
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling What do Cochrane systematic reviews say about diabetic retinopathy?Review [publication type]Diabetic retinopathyTherapeuticsEvidence-based medicineEvidence-based practiceCONTEXT AND OBJECTIVE: Diabetic retinopathy is a disease caused by increased permeability of retinal vessels. Its incidence and prevalence have been increasing due to urbanization, greater life expectancy and the habits of modern life. Its onset is insidious and it may lead to blindness in 75% of individuals who have been diabetic for more than 20 years. The aim here was to evaluate the evidence from Cochrane systematic reviews on interventions relating to diabetic retinopathy. DESIGN AND SETTING: Review of systematic reviews, conducted at Cochrane Brazil. METHODS: We included Cochrane systematic reviews on interventions relating to diabetic retinopathy. Two researchers evaluated the inclusion criteria, summarized the reviews and presented the results narratively. RESULTS: Ten reviews met the inclusion criteria. They showed some evidence of benefits from: (a) photocoagulation for diabetic retinopathy(b) strict glucose and pressure control for postponing the onset of retinopathy(c) antiangiogenic drugs for macular edema (high-quality evidence)(d) anti-vascular endothelial growth factor agents for proliferative diabetic retinopathy (very low to low-quality evidence)and (e) intravitreal injection or surgical implantation for treating persistent or refractory macular edema. However, blood pressure control seems to have no benefit after the onset of retinopathy. CONCLUSION: Only a few options are likely to be effective for treating diabetic retinopathy. These include photocoagulation and anti-vascular endothelial growth factor agents. Strict glucose and pressure control seem to postpone the onset of retinopathy. For macular edema, antiangiogenic drugs, intravitreal injection and surgical implantation seem to have some benefit.Univ Fed Sao Paulo Unifesp, Discipline Evidence Based Med, EPM, Sao Paulo, BrazilHosp Dante Pazzanese Cardiol, Dyslipidemia Serv, Sao Paulo, SP, BrazilUniv Fed Sao Paulo Unifesp, Evidence Based Hlth Program, Sao Paulo, SP, BrazilUniv Fed Sao Paulo Unifesp, Med, EPM, Sao Paulo, SP, BrazilCochrane Brazil, Sao Paulo, SP, BrazilEscola Paulista de Medicina (EPM), Universidade Federal de São Paulo (Unifesp), São Paulo (SP), BrazilDiscipline of Evidence-Based Medicine, Escola Paulista de Medicina (EPM), Universidade Federal de São Paulo (Unifesp)Evidence-Based Health Program, Universidade Federal de São Paulo (Unifesp), São Paulo (SP), BrazilCochrane Brazil, São Paulo (SP), BrazilWeb of ScienceAssociacao Paulista Medicina2020-07-31T12:46:45Z2020-07-31T12:46:45Z2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion79-87application/pdfhttp://dx.doi.org/10.1590/1516-3180.2016.0356040117Sao Paulo Medical Journal. Sao Paulo, v. 135, n. 1, p. 79-87, 2017.10.1590/1516-3180.2016.0356040117S1516-31802017000100079.pdf1516-3180S1516-31802017000100079https://repositorio.unifesp.br/handle/11600/56341WOS:000398127000013ark:/48912/001300000c1zgengSao Paulo Medical JournalSao Pauloinfo:eu-repo/semantics/openAccessMozetic, Vania [UNIFESP]Daou, Julia Pozzetti [UNIFESP]Martimbianco, Ana Luiza Cabrera [UNIFESP]Riera, Rachel [UNIFESP]reponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-11T10:53:31Zoai:repositorio.unifesp.br/:11600/56341Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-12-11T20:10:15.561737Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv What do Cochrane systematic reviews say about diabetic retinopathy?
title What do Cochrane systematic reviews say about diabetic retinopathy?
spellingShingle What do Cochrane systematic reviews say about diabetic retinopathy?
What do Cochrane systematic reviews say about diabetic retinopathy?
Mozetic, Vania [UNIFESP]
Review [publication type]
Diabetic retinopathy
Therapeutics
Evidence-based medicine
Evidence-based practice
Mozetic, Vania [UNIFESP]
Review [publication type]
Diabetic retinopathy
Therapeutics
Evidence-based medicine
Evidence-based practice
title_short What do Cochrane systematic reviews say about diabetic retinopathy?
title_full What do Cochrane systematic reviews say about diabetic retinopathy?
title_fullStr What do Cochrane systematic reviews say about diabetic retinopathy?
What do Cochrane systematic reviews say about diabetic retinopathy?
title_full_unstemmed What do Cochrane systematic reviews say about diabetic retinopathy?
What do Cochrane systematic reviews say about diabetic retinopathy?
title_sort What do Cochrane systematic reviews say about diabetic retinopathy?
author Mozetic, Vania [UNIFESP]
author_facet Mozetic, Vania [UNIFESP]
Mozetic, Vania [UNIFESP]
Daou, Julia Pozzetti [UNIFESP]
Martimbianco, Ana Luiza Cabrera [UNIFESP]
Riera, Rachel [UNIFESP]
Daou, Julia Pozzetti [UNIFESP]
Martimbianco, Ana Luiza Cabrera [UNIFESP]
Riera, Rachel [UNIFESP]
author_role author
author2 Daou, Julia Pozzetti [UNIFESP]
Martimbianco, Ana Luiza Cabrera [UNIFESP]
Riera, Rachel [UNIFESP]
author2_role author
author
author
dc.contributor.author.fl_str_mv Mozetic, Vania [UNIFESP]
Daou, Julia Pozzetti [UNIFESP]
Martimbianco, Ana Luiza Cabrera [UNIFESP]
Riera, Rachel [UNIFESP]
dc.subject.por.fl_str_mv Review [publication type]
Diabetic retinopathy
Therapeutics
Evidence-based medicine
Evidence-based practice
topic Review [publication type]
Diabetic retinopathy
Therapeutics
Evidence-based medicine
Evidence-based practice
description CONTEXT AND OBJECTIVE: Diabetic retinopathy is a disease caused by increased permeability of retinal vessels. Its incidence and prevalence have been increasing due to urbanization, greater life expectancy and the habits of modern life. Its onset is insidious and it may lead to blindness in 75% of individuals who have been diabetic for more than 20 years. The aim here was to evaluate the evidence from Cochrane systematic reviews on interventions relating to diabetic retinopathy. DESIGN AND SETTING: Review of systematic reviews, conducted at Cochrane Brazil. METHODS: We included Cochrane systematic reviews on interventions relating to diabetic retinopathy. Two researchers evaluated the inclusion criteria, summarized the reviews and presented the results narratively. RESULTS: Ten reviews met the inclusion criteria. They showed some evidence of benefits from: (a) photocoagulation for diabetic retinopathy
publishDate 2017
dc.date.none.fl_str_mv 2017
2020-07-31T12:46:45Z
2020-07-31T12:46:45Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/1516-3180.2016.0356040117
Sao Paulo Medical Journal. Sao Paulo, v. 135, n. 1, p. 79-87, 2017.
10.1590/1516-3180.2016.0356040117
S1516-31802017000100079.pdf
1516-3180
S1516-31802017000100079
https://repositorio.unifesp.br/handle/11600/56341
WOS:000398127000013
dc.identifier.dark.fl_str_mv ark:/48912/001300000c1zg
url http://dx.doi.org/10.1590/1516-3180.2016.0356040117
https://repositorio.unifesp.br/handle/11600/56341
identifier_str_mv Sao Paulo Medical Journal. Sao Paulo, v. 135, n. 1, p. 79-87, 2017.
10.1590/1516-3180.2016.0356040117
S1516-31802017000100079.pdf
1516-3180
S1516-31802017000100079
WOS:000398127000013
ark:/48912/001300000c1zg
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Sao Paulo Medical Journal
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 79-87
application/pdf
dc.coverage.none.fl_str_mv Sao Paulo
dc.publisher.none.fl_str_mv Associacao Paulista Medicina
publisher.none.fl_str_mv Associacao Paulista Medicina
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1822249735578189824
dc.identifier.doi.none.fl_str_mv 10.1590/1516-3180.2016.0356040117